サマリー

世界の細胞・遺伝子治療市場 2022-2026
Technavioは細胞・遺伝子治療市場を監視しており、2022-2026年の間に99億7000万ドルの成長が見込まれ、予測期間中にCAGR20.15%で加速しています。当レポートでは、細胞・遺伝子治療市場の全体分析、市場規模・予測、トレンド、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境について最新の分析を提供しています。市場は、慢性疾患の蔓延、特効薬指定の増加、細胞および遺伝子ベースの研究に対する資金提供の増加によって牽引されています。
細胞および遺伝子治療市場の分析には、タイプ別セグメントと地理的展望が含まれます。
Technavioの細胞および遺伝子治療市場は、以下のように区分されています。
タイプ別
- 細胞治療
- 遺伝子治療
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域(ROW)
本調査では、今後数年間における細胞・遺伝子治療市場の成長を促進する主な理由の1つとして、新興用途の医薬品開発への注目が高まっていることを挙げています。また、戦略的提携や発展途上国での急速な成長の可能性も、市場の大きな需要につながると考えられます。
Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。細胞および遺伝子治療市場に関する弊社のレポートは、以下の分野を対象としています。
- 細胞治療と遺伝子治療の市場サイジング
- 細胞治療と遺伝子治療の市場予測
- 細胞および遺伝子治療市場の産業分析
Technavioの堅牢なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Alnylam Pharmaceuticals Inc.、Amgen Inc.、Biogen Inc.、bluebird bio Inc.、Bristol Myers Squibb Co.、Castle Creek Biosciences Inc.、 CORESTEM Inc、Cytori Therapeutics Inc、Dendreon Pharmaceuticals LLC、Fering BV、Gilead Sciences Inc、Helixmith Co.(株)ヒト幹細胞研究所、JCR Pharmaceuticals Co.Ltd.、Kolon TissueGene Inc.、Novartis AG、Orchard Therapeutics Plc、Pfizer Inc.、Sibiono GeneTech Co.Ltd.、Vericel Corp.また、細胞・遺伝子治療市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/cell-and-gene-therapy-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Cell therapy - Market size and forecast 2021-2026
o Exhibit 28: Chart on Cell therapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Cell therapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Cell therapy - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Cell therapy - Year-over-year growth 2021-2026 (%)
o 5.4 Gene therapy - Market size and forecast 2021-2026
o Exhibit 32: Chart on Gene therapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Gene therapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Gene therapy - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Gene therapy - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Type
o Exhibit 36: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Japan - Market size and forecast 2021-2026
o Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Amgen Inc.
o Exhibit 85: Amgen Inc. - Overview
o Exhibit 86: Amgen Inc. - Product / Service
o Exhibit 87: Amgen Inc. - Key offerings
o 10.4 Biogen Inc.
o Exhibit 88: Biogen Inc. - Overview
o Exhibit 89: Biogen Inc. - Product / Service
o Exhibit 90: Biogen Inc. - Key offerings
o 10.5 bluebird bio Inc.
o Exhibit 91: bluebird bio Inc. - Overview
o Exhibit 92: bluebird bio Inc. - Product / Service
o Exhibit 93: bluebird bio Inc. - Key offerings
o 10.6 Bristol Myers Squibb Co.
o Exhibit 94: Bristol Myers Squibb Co. - Overview
o Exhibit 95: Bristol Myers Squibb Co. - Product / Service
o Exhibit 96: Bristol Myers Squibb Co. - Key offerings
o 10.7 CORESTEM Inc.
o Exhibit 97: CORESTEM Inc. - Overview
o Exhibit 98: CORESTEM Inc. - Product / Service
o Exhibit 99: CORESTEM Inc. - Key offerings
o 10.8 Dendreon Pharmaceuticals LLC.
o Exhibit 100: Dendreon Pharmaceuticals LLC. - Overview
o Exhibit 101: Dendreon Pharmaceuticals LLC. - Product / Service
o Exhibit 102: Dendreon Pharmaceuticals LLC. - Key offerings
o 10.9 JCR Pharmaceticals Co. Ltd.
o Exhibit 103: JCR Pharmaceticals Co. Ltd. - Overview
o Exhibit 104: JCR Pharmaceticals Co. Ltd. - Product / Service
o Exhibit 105: JCR Pharmaceticals Co. Ltd. - Key offerings
o 10.10 Novartis AG
o Exhibit 106: Novartis AG - Overview
o Exhibit 107: Novartis AG - Business segments
o Exhibit 108: Novartis AG - Key offerings
o Exhibit 109: Novartis AG - Segment focus
o 10.11 Pfizer Inc.
o Exhibit 110: Pfizer Inc. - Overview
o Exhibit 111: Pfizer Inc. - Product / Service
o Exhibit 112: Pfizer Inc. - Key news
o Exhibit 113: Pfizer Inc. - Key offerings
o 10.12 Vericel Corp.
o Exhibit 114: Vericel Corp. - Overview
o Exhibit 115: Vericel Corp. - Business segments
o Exhibit 116: Vericel Corp. - Key news
o Exhibit 117: Vericel Corp. - Key offerings
o Exhibit 118: Vericel Corp. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 119: Inclusions checklist
o Exhibit 120: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 121: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 122: Research methodology
o Exhibit 123: Validation techniques employed for market sizing
o Exhibit 124: Information sources
o 11.5 List of abbreviations
o Exhibit 125: List of abbreviations
o health: Includes veterinary drugs (excluded from the scope of the report)


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Cell therapy - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Cell therapy - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Cell therapy - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Cell therapy - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Gene therapy - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Gene therapy - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Amgen Inc. - Overview
Exhibits86: Amgen Inc. - Product / Service
Exhibits87: Amgen Inc. - Key offerings
Exhibits88: Biogen Inc. - Overview
Exhibits89: Biogen Inc. - Product / Service
Exhibits90: Biogen Inc. - Key offerings
Exhibits91: bluebird bio Inc. - Overview
Exhibits92: bluebird bio Inc. - Product / Service
Exhibits93: bluebird bio Inc. - Key offerings
Exhibits94: Bristol Myers Squibb Co. - Overview
Exhibits95: Bristol Myers Squibb Co. - Product / Service
Exhibits96: Bristol Myers Squibb Co. - Key offerings
Exhibits97: CORESTEM Inc. - Overview
Exhibits98: CORESTEM Inc. - Product / Service
Exhibits99: CORESTEM Inc. - Key offerings
Exhibits100: Dendreon Pharmaceuticals LLC. - Overview
Exhibits101: Dendreon Pharmaceuticals LLC. - Product / Service
Exhibits102: Dendreon Pharmaceuticals LLC. - Key offerings
Exhibits103: JCR Pharmaceticals Co. Ltd. - Overview
Exhibits104: JCR Pharmaceticals Co. Ltd. - Product / Service
Exhibits105: JCR Pharmaceticals Co. Ltd. - Key offerings
Exhibits106: Novartis AG - Overview
Exhibits107: Novartis AG - Business segments
Exhibits108: Novartis AG - Key offerings
Exhibits109: Novartis AG - Segment focus
Exhibits110: Pfizer Inc. - Overview
Exhibits111: Pfizer Inc. - Product / Service
Exhibits112: Pfizer Inc. - Key news
Exhibits113: Pfizer Inc. - Key offerings
Exhibits114: Vericel Corp. - Overview
Exhibits115: Vericel Corp. - Business segments
Exhibits116: Vericel Corp. - Key news
Exhibits117: Vericel Corp. - Key offerings
Exhibits118: Vericel Corp. - Segment focus
Exhibits119: Inclusions checklist
Exhibits120: Exclusions checklist
Exhibits121: Currency conversion rates for US$
Exhibits122: Research methodology
Exhibits123: Validation techniques employed for market sizing
Exhibits124: Information sources
Exhibits125: List of abbreviations